...
机译:一周剂量茂密化疗,在一线上皮卵巢卵巢,输卵管,或初级腹膜癌治疗(ICON8):主要进展免费存活分析来自GCIG第3期随机对照试验
Christie Natl Hlth Serv Fdn Trust Dept Med Oncol Manchester Lancs England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
Imperial Coll London Dept Surg &
Canc London England;
St John God Hosp Dept Oncol Subiaco WA Australia;
Seoul Natl Univ Dept Obstet &
Gynaecol Seoul South Korea;
Canc Trials Ireland Dublin Ireland;
St James Univ Hosp Leeds W Yorkshire England;
Portsmouth Hosp Natl Hlth ServiceTrust Queen Alexandra Hosp Portsmouth Hants England;
Univ Oxford Churchill Hosp Oxford England;
Canc Res UK Cambridge Inst Li Ka Shing Ctr Cambridge England;
Queen Elizabeth Hosp Gynaecol Oncol Ctr Gateshead England;
St James Univ Hosp Leeds W Yorkshire England;
Univ Birmingham Inst Canc &
Genom Birmingham W Midlands England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
Imperial Coll London Dept Surg &
Canc London England;
Clatterbridge Canc Ctr Dept Oncol Wirral Merseyside England;
Freeman Rd Hosp Northern Ctr Canc Care Newcastle Upon Tyne Tyne &
Wear England;
Addenbrookes Hosp Dept Med Oncol Cambridge England;
Mt Vernon Canc Ctr Dept Med Oncol Northwood Middx England;
Royal Marsden Natl Hlth Serv Fdn Trust Gynaecol Unit London England;
Beatson West Scotland Canc Ctr Glasgow Lanark Scotland;
Velindre Canc Ctr Cardiff S Glam Wales;
Birmingham City Hosp Birmingham W Midlands England;
Univ East Anglia Norwich Med Sch Norwich Norfolk England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
UCL Clin Trials Unit MRC Inst Clin Trials &
Methodol London WC1V6LJ England;
UCL Inst Canc London England;
机译:一周剂量茂密化疗,在一线上皮卵巢卵巢,输卵管,或初级腹膜癌治疗(ICON8):主要进展免费存活分析来自GCIG第3期随机对照试验
机译:聚乙二醇化脂质体阿霉素(JNS002)在日本米勒癌(上皮性卵巢癌,输卵管原发癌,腹膜癌)患者中的铂类化学疗法的II期临床试验:日本妇科肿瘤学的II期研究组
机译:干扰素gamma-1b加标准卡铂/紫杉醇与卡铂/紫杉醇单独用于晚期卵巢癌和原发性腹膜癌一线治疗的随机3期试验:前瞻性设计无进展生存分析的结果
机译:PIPAC-OV3:一项多中心开放标签随机三臂III期临床试验对加压铂-腹膜内气雾剂化疗(PIPAC)与单独化疗的铂-铂类患者对顺铂和阿霉素的无进展生存期有影响耐药的复发性上皮性卵巢癌输卵管癌或原发性腹膜癌
机译:一周剂量茂密化疗,在一线上皮卵巢卵巢,输卵管,或初级腹膜癌治疗(ICON8):主要进展免费存活分析来自GCIG第3期随机对照试验